Larvol Delta - Prognostic-Value-of-the-Lung-Immune-Prognostic-Index-and-an-ECOGAlbuminLIPI-Nomogram-in-Metastatic-NSCLC-Patients-Treated-with-Second-or-ThirdLine-Nivolumab

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

http://www.ncbi.nlm.nih.gov/pubmed/42739873

Ahmet Küçükarda; Dicle Yurdatap Koç; Ece Demirdelen

Sep 16, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next